Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Appendix
Available only for authorised users
Literature
1.
Dohner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424–447CrossRef
2.
de Guzman CG, Warren AJ, Zhang Z et al (2002) Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol Cell Biol 22(15):5506–5517CrossRef
3.
Yuan Y, Zhou L, Miyamoto T et al (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 98(18):10398–10403CrossRef
4.
Klampfl T, Gisslinger H, Harutyunyan AS et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369(25):2379–2390CrossRef
5.
Nangalia J, Massie CE, Baxter EJ et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369(25):2391–2405CrossRef
6.
Heuser M, Panagiota V, Koenecke C et al (2014) Low frequency of calreticulin mutations in MDS patients. Leukemia 28(9):1933–1934CrossRef
7.
Theocharides AP, Lundberg P, Lakkaraju AK et al (2016) Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. Blood 127(25):3253–3259CrossRef
8.
Shahin OA, Ravandi F (2020) Myeloid sarcoma. Curr Opin Hematol 27(2):88–94CrossRef
9.
Pileri SA, Ascani S, Cox MC et al (2007) Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21(2):340–350CrossRef
10.
Shide K, Kameda T, Kamiunten A et al (2020) Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice. Blood 136(1):106–118PubMedPubMedCentral
Metadata
Title
CALR loss-of-heterozygosity as a potential driver for extramedullary AML
Authors
Marie-Christine Weller
Eugenia Haralambieva
Marco Matteo Bühler
Rudolf Benz
Alexandre Pierre André Theocharides
Stefan Balabanov
Publication date
26-09-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-022-04976-8

Other articles of this Issue 11/2022

Annals of Hematology 11/2022 Go to the issue

Letter to the Editor

Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation

Review Article

Circulating tumor DNA in Hodgkin lymphoma

Original Article

B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis

Letter to the Editor

Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation

Original Article

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016

Original Article

L-DEP regimen is effective as an initial therapy for adult EBV-HLH

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits